Gene: LRP2

4036
DBS|GP330
LDL receptor related protein 2
protein-coding
2q31.1
Ensembl:ENSG00000081479 MIM:600073 Vega:OTTHUMG00000132179 UniprotKB:P98164
NG_012634.1
PubMed
0   ANCO-SNPs
ND|AD
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
3.354e-1 (AD)  1.941e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PIEZO20.919
IP6K30.906
ST180.903
LGR50.902
SLC45A30.892
MYO1D0.887
C10orf900.886
DNAH170.885
ANLN0.884
SH3TC20.882

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
CALB2-0.393
PRTN3-0.392
CUX2-0.38
SLC29A4-0.376
LTK-0.362
SHISA8-0.35
CCDC85C-0.349
KAZALD1-0.348
PCDH8-0.341
CHRNA2-0.34

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00013UrokinaseBiotechDrug9039-53-6Approved|Investigational|WithdrawnTarget
DB00030Insulin HumanBiotechDrug11061-68-0Approved|InvestigationalTarget
DB00071Insulin PorkBiotechDrug12584-58-6ApprovedTarget
DB00798GentamicinSmall Molecule1403-66-3ApprovedTarget
ID Drug Name Action PubMed
C0388902,3,4,7,8-pentachlorodibenzofuran"2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of LRP2 mRNA"21724226
C0164032,4-dinitrotoluene"2,4-dinitrotoluene affects the expression of LRP2 mRNA"21346803
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of LRP2 mRNA"21346803
C0065512-amino-2-methyl-1-propanol2-amino-2-methyl-1-propanol results in decreased expression of LRP2 mRNA25088246
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LRP2 mRNA"23994337
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C496492abrineabrine results in increased expression of LRP2 mRNA22595364
C040534alpha-hexachlorocyclohexanealpha-hexachlorocyclohexane results in decreased expression of LRP2 mRNA16940010
C057620bafilomycin Abafilomycin A inhibits the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D019324beta-Naphthoflavonebeta-Naphthoflavone results in increased expression of LRP2 mRNA23994337
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D004958EstradiolEstradiol promotes the reaction [Plant Preparations results in decreased expression of LRP2 mRNA]26945725
D004958EstradiolEstradiol results in decreased expression of LRP2 mRNA26945725
C095105bexarotenebexarotene results in decreased expression of LRP2 mRNA16648578
C006780bisphenol Abisphenol A affects the expression of LRP2 mRNA20170705
C006780bisphenol Abisphenol A affects the expression of LRP2 mRNA25181051
C006780bisphenol Abisphenol A results in decreased expression of LRP2 mRNA29097150
C006780bisphenol Abisphenol A results in increased methylation of LRP2 gene28505145
D002104CadmiumCadmium results in decreased expression of LRP2 mRNA24376830
D002104Cadmium[LRPAP1 protein affects the localization of LRP2 protein] which results in decreased uptake of Cadmium22617749
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of LRP2 mRNA18804290
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of LRP2 mRNA29286200
D019256Cadmium Chloridebafilomycin A inhibits the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D019256Cadmium Chloridebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of LRP2 mRNA20576581
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of LRP2 protein20576581
D019256Cadmium ChlorideCadmium Chloride results in increased degradation of LRP2 protein20576581
D019256Cadmium ChlorideCycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D002220CarbamazepineCarbamazepine affects the expression of LRP2 mRNA25979313
D002635Chenodeoxycholic AcidChenodeoxycholic Acid results in increased expression of LRP2 protein15375181
D002635Chenodeoxycholic AcidNR1H4 protein promotes the reaction [Chenodeoxycholic Acid results in increased expression of LRP2 protein]15375181
D002635Chenodeoxycholic AcidChenodeoxycholic Acid results in increased expression of LRP2 protein15375181
D002737ChloropreneChloroprene results in decreased expression of LRP2 mRNA23125180
D019826Cholic AcidCholic Acid results in increased expression of LRP2 protein15375181
D019826Cholic AcidNR1H4 protein promotes the reaction [Cholic Acid results in increased expression of LRP2 protein]15375181
D019826Cholic AcidCholic Acid results in increased expression of LRP2 protein15375181
D002922CiguatoxinsCiguatoxins affects the expression of LRP2 mRNA18353800
C018021cobaltous chloridecobaltous chloride results in decreased expression of LRP2 mRNA24386269
D003078ColchicineColchicine affects the localization of LRP2 protein25588984
D003471CuprizoneCuprizone results in decreased expression of LRP2 mRNA27523638
D003513CycloheximideCycloheximide promotes the reaction [Cadmium Chloride results in decreased expression of LRP2 protein]20576581
D003513CycloheximideCycloheximide results in decreased expression of LRP2 protein20576581
D016572CyclosporineCyclosporine results in decreased expression of LRP2 mRNA20106945
D002945Cisplatin[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of LRP2 mRNA23625948
D002945CisplatinCisplatin results in increased phosphorylation of LRP2 protein22006019
D004041Dietary FatsDietary Fats results in decreased expression of LRP2 mRNA25016146
C118739entinostatentinostat results in decreased expression of LRP2 mRNA26272509
C118739entinostatentinostat results in increased expression of LRP2 mRNA27188386
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of LRP2 mRNA20170705|2686566
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of LRP2 mRNA18936297
D004997Ethinyl EstradiolEthinyl Estradiol affects the expression of LRP2 mRNA20170705|2686566
D004997Ethinyl EstradiolEthinyl Estradiol results in decreased expression of LRP2 mRNA15834898|1617478
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of LRP2 mRNA16940010
D005038EthylnitrosoureaEthylnitrosourea results in increased mutagenesis of LRP2 mRNA27776689
C540355fenamidonefenamidone results in increased expression of LRP2 mRNA27029645
C039281furanfuran results in decreased expression of LRP2 mRNA26194646
D019833GenisteinGenistein results in decreased expression of LRP2 mRNA26865667
D019833GenisteinGenistein results in decreased expression of LRP2 mRNA22553218
D005839GentamicinsGentamicins results in increased expression of LRP2 protein26779593
D005839GentamicinsSodium Fluoride inhibits the reaction [Gentamicins results in increased expression of LRP2 protein]26779593
C018562guggulu extractguggulu extract results in increased expression of LRP2 protein15375181
C018562guggulu extractNR1H4 protein promotes the reaction [guggulu extract results in increased expression of LRP2 protein]15375181
D017313FenretinideFenretinide results in increased expression of LRP2 mRNA28973697
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of LRP2 mRNA20044591
D008095Lithocholic AcidLithocholic Acid results in decreased expression of LRP2 protein15375181
D008095Lithocholic AcidLithocholic Acid affects the expression of LRP2 protein15375181
D008095Lithocholic AcidLithocholic Acid binds to and results in increased activity of LRP2 protein15375181
D008713MethimazoleMethimazole results in increased expression of LRP2 mRNA22342233
D008713MethimazoleMethimazole results in increased expression of LRP2 mRNA22342233
D008727MethotrexateMethotrexate results in increased expression of LRP2 mRNA24449571
D008748MethylcholanthreneMethylcholanthrene results in decreased expression of LRP2 mRNA18804290
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of LRP2 mRNA28001369
C014707nitrosobenzylmethylaminenitrosobenzylmethylamine results in decreased expression of LRP2 mRNA17616710
D010047Ovalbumin[Ovalbumin affects the susceptibility to Particulate Matter] which results in decreased expression of LRP2 mRNA19176365
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C496932panobinostatpanobinostat results in decreased expression of LRP2 mRNA26272509
D052638Particulate Matter[Ovalbumin affects the susceptibility to Particulate Matter] which results in decreased expression of LRP2 mRNA19176365
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid affects the expression of LRP2 mRNA19429403
C023036perfluorooctanoic acidperfluorooctanoic acid affects the expression of LRP2 mRNA19429403
D010705PhosgenePhosgene affects the expression of LRP2 mRNA16300373
D028321Plant PreparationsEstradiol promotes the reaction [Plant Preparations results in decreased expression of LRP2 mRNA]26945725
D028321Plant PreparationsPlant Preparations results in decreased expression of LRP2 mRNA26945725
C023617pregna-4,17-diene-3,16-dione"NR1H4 protein promotes the reaction [pregna-4,17-diene-3,16-dione results in increased expression of LRP2 protein]"15375181
C023617pregna-4,17-diene-3,16-dione"pregna-4,17-diene-3,16-dione results in increased expression of LRP2 protein"15375181
D011374ProgesteroneProgesterone affects the expression of LRP2 mRNA17251523
D011374ProgesteroneProgesterone results in decreased expression of LRP2 mRNA19690047
D011441PropylthiouracilPropylthiouracil results in decreased expression of LRP2 mRNA22342233
D011441PropylthiouracilPropylthiouracil affects the expression of LRP2 mRNA24780913
D011441PropylthiouracilPropylthiouracil results in increased expression of LRP2 mRNA22342233
C010313pseudocumenepseudocumene results in decreased expression of LRP2 protein17337753
C513428pyrachlostrobinpyrachlostrobin results in increased expression of LRP2 mRNA27029645
C089730rosiglitazonerosiglitazone results in decreased expression of LRP2 mRNA21515302
D012715Sesame OilSesame Oil results in decreased expression of LRP2 mRNA29191790
C017947sodium arsenitesodium arsenite affects the methylation of LRP2 gene28589171
C016104sodium bichromatesodium bichromate results in decreased expression of LRP2 mRNA25993096
D012969Sodium FluorideSodium Fluoride results in increased expression of LRP2 protein28918527
D012969Sodium FluorideSodium Fluoride inhibits the reaction [Gentamicins results in increased expression of LRP2 protein]26779593
D053260SootSoot results in increased expression of LRP2 mRNA22461453
C501413tesaglitazartesaglitazar results in increased expression of LRP2 mRNA21515302
C020806tetrabromobisphenol Atetrabromobisphenol A results in increased expression of LRP2 mRNA28300664
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of LRP2 mRNA22298810
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of LRP2 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of LRP2 mRNA28213091
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of LRP2 mRNA15800033|1646718
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of LRP2 mRNA22298810
D013792ThalidomideThalidomide results in increased expression of LRP2 mRNA28892372
C009495titanium dioxidetitanium dioxide results in increased expression of LRP2 mRNA23557971
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C012589trichostatin Atrichostatin A results in decreased expression of LRP2 mRNA24935251|2627250
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of LRP2 mRNA19042947
C057693troglitazonetroglitazone results in decreased expression of LRP2 mRNA21515302
D014635Valproic AcidValproic Acid affects the expression of LRP2 mRNA25979313
D014635Valproic AcidValproic Acid results in decreased expression of LRP2 mRNA24383497|2493525
D014635Valproic AcidValproic Acid results in decreased methylation of LRP2 gene29154799
D014635Valproic AcidValproic Acid results in increased expression of LRP2 mRNA23179753|2519280
D014635Valproic AcidValproic Acid results in increased expression of LRP2 mRNA19136453
C029297vinylidene chloridevinylidene chloride results in decreased expression of LRP2 mRNA26682919
D014801Vitamin ALRP2 protein results in increased uptake of and affects the abundance of Vitamin A16251603
D014807Vitamin DLRP2 protein binds to and results in increased uptake of [Vitamin D binds to GC protein]10052453
D002762CholecalciferolCholecalciferol results in increased expression of LRP2 mRNA17170073
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP2 mRNA"27188386
C111237vorinostatvorinostat results in decreased expression of LRP2 mRNA26272509
C111237vorinostatvorinostat results in increased expression of LRP2 mRNA27188386
D015034Zinc OxideZinc Oxide analog results in increased expression of LRP2 mRNA27215404

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005041low-density lipoprotein particle receptor activity-TAS-  
GO:0005509calcium ion binding-IDA23275343  
GO:0005515protein binding-IPI9773776  23825075  
GO:0008144drug binding-ISS-  
GO:0017124SH3 domain binding-IEA-  
GO:0035258steroid hormone receptor binding-ISS-  
GO:0042954lipoprotein transporter activity-TAS-  
GO:0051087chaperone binding-IPI9228033  
GO:0051087chaperone binding-ISS9228033  
GO ID GO Term Qualifier Evidence PubMed
GO:0001523retinoid metabolic process-TAS-  
GO:0001843neural tube closure-ISS-  
GO:0003139secondary heart field specification-ISS-  
GO:0003148outflow tract septum morphogenesis-ISS-  
GO:0003223ventricular compact myocardium morphogenesis-ISS-  
GO:0003281ventricular septum development-IEA-  
GO:0006629lipid metabolic process-TAS7768901  
GO:0006897endocytosis-TAS7768901  
GO:0006898receptor-mediated endocytosis-IDA23825075  
GO:0006898receptor-mediated endocytosis-ISS9228033  
GO:0007605sensory perception of sound-ISS-  
GO:0008283cell proliferation-IEA-  
GO:0008584male gonad development-ISS-  
GO:0030001metal ion transport-IDA15126248  
GO:0030514negative regulation of BMP signaling pathway-ISS-  
GO:0030900forebrain development-IEA-  
GO:0035904aorta development-IEA-  
GO:0042359vitamin D metabolic process-TAS-  
GO:0042953lipoprotein transport-IEA-  
GO:0050769positive regulation of neurogenesis-ISS-  
GO:0060068vagina development-ISS-  
GO:0060982coronary artery morphogenesis-ISS-  
GO:0061024membrane organization-TAS-  
GO:0061156pulmonary artery morphogenesis-ISS-  
GO:0070447positive regulation of oligodendrocyte progenitor proliferation-ISS-  
GO:0140058neuron projection arborization-ISS-  
GO:1904447folate import across plasma membrane-ISS-  
GO:1905167positive regulation of lysosomal protein catabolic process-ISS9228033  
GO ID GO Term Qualifier Evidence PubMed
GO:0005764lysosome-TAS7768901  
GO:0005765lysosomal membrane-HDA17897319  
GO:0005783endoplasmic reticulum-IEA-  
GO:0005794Golgi apparatus-IEA-  
GO:0005886plasma membrane-TAS-  
GO:0005905clathrin-coated pit-IEA-  
GO:0009897external side of plasma membrane-ISS-  
GO:0016021integral component of membrane-IEA-  
GO:0016324apical plasma membrane-IDA23825075  
GO:0016324apical plasma membrane-ISS-  
GO:0030139endocytic vesicle-IEA-  
GO:0030424axon-ISS-  
GO:0030425dendrite-ISS-  
GO:0030665clathrin-coated vesicle membrane-TAS-  
GO:0031526brush border membrane-ISS-  
GO:0031904endosome lumen-IEA-  
GO:0043235receptor complex-IDA23382219  
GO:0070062extracellular exosome-HDA19056867  23533145  
KEGG ID KEGG Term
hsa04340Hedgehog signaling pathway
Reactome ID Reactome Term Evidence
R-HSA-1430728MetabolismTAS
R-HSA-162582Signal TransductionTAS
R-HSA-196791Vitamin D (calciferol) metabolismTAS
R-HSA-196854Metabolism of vitamins and cofactorsTAS
R-HSA-199991Membrane TraffickingTAS
R-HSA-2187338Visual phototransductionTAS
R-HSA-372790Signaling by GPCRTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-418594G alpha (i) signalling eventsTAS
R-HSA-556833Metabolism of lipidsTAS
R-HSA-5653656Vesicle-mediated transportTAS
R-HSA-6806667Metabolism of fat-soluble vitaminsTAS
R-HSA-8856825Cargo recognition for clathrin-mediated endocytosisTAS
R-HSA-8856828Clathrin-mediated endocytosisTAS
R-HSA-8957322Metabolism of steroidsTAS
R-HSA-975634Retinoid metabolism and transportTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
24890784Exon microarray analysis of human dorsolateral prefrontal cortex in alcoholism. (2014 Jun)Manzardo AMAlcohol Clin Exp Res
25189868Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. (2015 Mar)Sung YJAm J Hypertens